Dianthus Therapeutics, Inc. Announces Closing of its Upsized $719 Million Underwritten Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Press Release
44th Annual J.P. Morgan Healthcare Conference Jan 12, 2026 3:00 PM PST Webcast Supporting Materials 44th Annual J.P. Morgan Healthcare Conference Presentation 2.2 MB
